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A B S T R A C T   
Snakebites cause upwards of 1.8 million envenomings, 138,000 deaths and 500,000 cases of long term morbidity 
each year. Viper snake venoms (family Viperidae) generally contain a high proportion of proteases which can 
cause devastating effects such as hemorrhage, coagulopathy, edema, necrosis, and severe pain, in envenomed 
victims. In this study, analytical techniques were combined with enzymatic assays to develop a novel method for 
the detection of snake venom protease activity by using rhodamine-110-peptide substrate. In the so called at-line 
nanofractionation set up, crude venoms were first separated with reversed phase liquid chromatography, after 
which fractions were collected onto 384-well plates. Protease activity assays were then performed in the 384-well 
plates and bioassay chromatograms were constructed revealing protease activity. Parallel obtained UV absor-
bance, MS and proteomics data from a previous study facilitated toxin identification. The application of the 
rhodamine-110-peptide substrate assay showed significantly greater sensitivity compared to prior assays using 
casein-FITC as the substrate. Moreover, cross referencing UV and MS data and resulted in the detection of a 
number of tentative proteases suspected to exhibit protease activity, including snake venom serine proteases 
from Calloselasma rhodostoma and Daboia russelli venom and a snake venom metalloproteinase from the venom of 
Echis ocellatus. Our data demonstrate that his methodology can be a useful tool for selectively identifying snake 
venom proteases, and can be applied to provide a better understanding of protease-induced pathologies and the 
development of novel therapeutics for treating snakebite.   
1. Introduction 
Proteases are key enzymes that perform myriad functions in various 
physiological systems, including those relating to digestion, hemostasis, 
apoptosis, signal transduction, blood coagulation, and immune re-
sponses. Snake venoms are rich in enzymatic proteins with diverse 
specificity and activity (Hedstrom, 2002; Schauperl et al., 2015). These, 
and other non-enzymatic venom components, exhibit complex evolu-
tionary histories, which have resulted in snake venoms containing a 
complex mixture of numerous protein/peptide components that are 
used for prey capture (Fry et al., 2008). Thus, the composition of snake 
venom —even within a species— is often highly variable and is influ-
enced by any number of external factors, such as the snake’s age or diet, 
geographical location, or the season of the year (Chippaux et al., 1991). 
In snake venom, particularly those of vipers, proteases are key toxin 
types involved in causing severe pathologies such as hemorrhage, coa-
gulopathy, edema, and intense local pain at the bite site (Kini and Koh, 
2016). These various clinical signs can in part be attributed to the ac-
tivity of snake venom metalloproteases (SVMPs), which destroy capil-
lary blood cells and surrounding tissues, the basement membrane, and 
vascular and muscular tissues (Arpitha et al., 2017; Guti�errez et al., 
2016). Another class of relevant snake venom protease toxins, the snake 
* Corresponding author. 
E-mail address: j.kool@vu.nl (J. Kool).  
Contents lists available at ScienceDirect 
Toxicon 
journal homepage: http://www.elsevier.com/locate/toxicon 
https://doi.org/10.1016/j.toxicon.2020.02.015 
Received 27 November 2019; Received in revised form 22 January 2020; Accepted 11 February 2020   
Toxicon 178 (2020) 61–68
62
venom serine proteases (SVSPs), interfere with blood coagulation by 
activating coagulation pathways and exerting fibrinogenolytic activ-
ities, resulting in the depletion of fibrinogen, and thus contributing to a 
life threatening pathology called venom induced consumption coagul-
opathy (Kini, 2005). If left untreated, the hemotoxic effects of these 
snake venom proteases, along with other venom toxins, can cause 
extravasation, catastrophic losses of blood pressure and extensive local 
tissue necrosis. 
Snakebite is a neglected tropical disease that affects millions of 
people each year, and results in more than 100,000 deaths annually and 
400,000 injuries (Guti�errez et al., 2017). Snakebite is treated via the use 
of intravenously delivered polyclonal antibody therapies known as an-
tivenom. However, due to a variety of biological and socioeconomic 
factors, including poor cross-snake species efficacy (Casewell et al., 
2014), high cost and low availability (Guti�errez et al., 2017), antivenom 
accessibility is often deficient in many of the impoverished rural com-
munities that face the highest risks of snakebite. Understanding the 
function and variation of snake venom components is crucial to devel-
oping more effective and affordable snakebite treatments, in addition to 
uncovering potentially therapeutic compounds (Slagboom et al., 2017). 
For the above reasons, inhibiting snake venom protease activity is of 
particular importance because these enzymes are often responsible for 
causing severe, often life-threatening, pathologies. 
To better understand the composition and function of snake venoms, 
we have developed an analytical “nanofractionation” platform capable 
of separating and fractionating venoms, and correlating observed 
bioactivity of fractions - using custom bioassays - with parallel acquired 
accurate masses of the venom components (Mladic et al., 2017; Mladic 
et al., 2016; Mladic et al., 2015). In this study, we sought to employ our 
nanofractionation platform for the characterization of proteases in snake 
venom. For that purpose, we developed a new generic fluorescence 
bioassay based on a rhodamine substrate to assess protease activity, 
aiming to circumvent limitations of the conventional casein-FITC assay 
(Huang et al., 2002; Nok, 2001). The new bioassay was integrated with 
liquid chromatography-mass spectrometry (LC-MS) methods to create a 
nanofractionation system for the simultaneous assessment of the 
bioactivity and identity of proteases present in snake venoms. The 
applicability of the platform was tested by profiling venoms of eight 
diverse viperid snake species. 
2. Experimental 
A Shimadzu UPLC system (SIL-30AC autosampler, DGU-20A degas-
ser, LC30AD pumps, and SPD-M20A PDA detector) equipped with a C18 
XBridge column (4.6 � 150 mm; 3.5 μm particle size) was used for LC 
separations. MS detection was performed using a MaXis HD qTOF in-
strument equipped with a standard ESI probe operating in positive mode 
(Bruker Daltonics, Bremen Germany). Greiner Bio-one black 384-well 
microtiter plates (Monroe, NC, USA) were used for collecting fractions 
and subsequent fluorescence experiments. 
Lyophilized snake venoms were obtained from the Herpetarium of 
the Centre for Snakebite Research & Interventions at the Liverpool 
School of Tropical Medicine (UK) and from Latoxan (France). Snake 
venoms were from the following viper (Viperidae) species: Calloselasma 
rhodostoma (Malaysia), Daboia russelii russelii (Sri Lanka), Echis carinatus 
(India), Echis coloratus (Egypt), Echis ocellatus (Nigeria), Echis pyramidum 
leakeyi (Kenya), Lachesis muta (Costa Rica) and Macrovipera lebetina 
(Uzbekistan). These venoms were selected based on either their medical 
importance or to cover broad geographical distribution (e.g. worldwide 
coverage). Venoms were reconstituted in water and aliquots were stored 
at   80 �C before analysis and at   20 �C between analyses. 
Rhodamine-110 bis-(p-tosyl-L-glycyl-L-prolyl-L-arginine amide) 
(referred to as rhodamine substrate) and leupeptin were purchased from 
ThermoFisher. Casein-FITC and solvents were purchased from Sigma- 
Aldrich. Milli-Q ultrapure water was obtained through an in-house 
Millipore filtration system. The fluorescence bioassay was conducted 
in phosphate buffer (PBS) (pH 7.4), which was also used to dilute sub-
strate solutions. A ThermoFisher Varioskan plate reader with standard 
SkanIt software was used to record the fluorescence readout of the 
bioassay. 
2.1. Fluorescence bioassay development 
All fluorescence experiments were conducted in 384-well microtiter 
plates using the Varioskan plate reader. Measurements were performed 
at 37 �C, using an excitation wavelength of 485 nm and emission 
wavelength of 535 nm. The final volume of all wells was 50 μL. Crude 
venom was diluted in MilliQ water, while substrates were diluted in PBS 
(137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4). To 
determine the minimum venom concentration required to observe pro-
tease activity, crude venom was diluted with MilliQ in series resulting in 
five experimental concentrations (33, 11, 4, 1 and 0.4 μg/mL). Of each 
venom concentration, 5 μL was added to 45 μL of PBS/substrate solution 
(10 μg/mL casein-FITC in PBS or 1 μM rhodamine substrate in PBS). The 
ensuing reaction was monitored by the plate reader for 15 min for either 
substrate. All venoms were assayed with both substrates. The appro-
priate/optimal substrate concentration required for the fluorescence 
bioassay was determined by measuring the fluorescence reaction rate for 
snake venoms in different starting concentrations with different sub-
strate concentrations. Final casein-FITC substrate concentrations per 
well were 30, 10, and 5 μg/mL, and for the rhodamine substrate, final 
concentrations were 1, 500, and 100 nM. Of each casein-FITC substrate 
solution (300, 100, or 50 μg/mL) and rhodamine solution (10, 5, and 1 
μM) 5 μL were incubated with 5 μL of crude snake venom (varyingrent 
concentrations) in 40 μL of PBS. The ensuing reactions were recorded for 
15 min for all cases. 
2.2. Nanofractionation system 
The LC setup with parallel fractionation and MS detection used in 
this study was based on previously developed workflows (Mladic et al., 
2016; Mladic et al., 2015). The eluent flow rate of 0.5 mL/min was 
controlled by two Shimadzu LC-30AD parallel pumps. Mobile phase A 
was made up of 98% water, 2% acetonitrile (ACN) and 0.1% formic acid 
(FA), and mobile phase B was 98% ACN, 2% water and 0.1% FA. The 
following LC gradient was applied: a linear increase from 0 to 50% B in 
20 min, followed by a linear increase from 50% to 90% B in 4 min, 
followed by isocratic elution at 90% B for 5 min. Equilibration was 
achieved by a decrease from 90 to 0% B in 1 min followed by 10 min 
isocratic elution at 0% B. The column effluent was split in a 1 to 9 ratio 
diverting 10% of the flow to a PDA detector followed by the Q-TOF mass 
spectrometer. The remaining 90% of the UPLC eluent was collected as 
6-s fractions in 384-well microtiter plates using a FractioMate™ 
(SPARK-Holland & VU, Netherlands, Emmen & Amsterdam) controlled 
by FractioMator software (Spark-Holland) or using an in-house built 
fraction collector based on a modified Gilson 235P autosampler 
controlled by in-house produced Ariadne software. MS data was ac-
quired in positive mode from 50 to 3000 m/z using the following con-
ditions: capillary voltage, 4500 V; nebulizer pressure, 0.4 Bar; dry gas 
flow, 4 L/min; dry gas temperature, 200 �C; collision cell energy, 6 eV; 
energy funnel 1 RF and multiple RF amplitudes, 400 V; quadrupole ion 
energy, 3 eV; collision RF, 1000 V. 
Well plates with LC fractions were evaporated to dryness in a Christ 
RVC 2-33CDplus rotational vacuum concentrator and stored at   20 �C 
until assayed. Plates with fractionated venom were subjected to bio-
assays utilizing either the rhodamine or casein-FITC substrate. Both 
bioassays were performed by adding 50 μL substrate/buffer solution per 
well, followed by fluorescence measurement under the aforementioned 
plate reader conditions. The optimized concentrations of substrate per 
well were 10 μg/mL casein-FITC or 500 nM rhodamine substrate. 
Rhodamine substrate and casein-FITC reactions were monitored for 30 
and 15 min, respectively. For each well, the slope of the increasing 
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fluorescence signal over time was plotted against the LC retention time 
of the probed fraction in order to generate a bioactivity chromatogram. 
Positive peaks in the obtained profile representing protease activity 
were correlated, with the parallel recorded UV and MS chromatograms 
allowing assignment of accurate molecular masses to active venom 
components. 
3. Results and discussion 
The aim of this project was to develop a fluorescence bioassay to 
detect individual proteases in snake venoms following chromatographic 
separation and fractionation. Studies relating to snake venom protease 
activity have traditionally relied on casein-based protease substrates 
such as casein-FITC (Arpitha et al., 2017; Borges et al., 2001; Choudhury 
et al., 2017; Cupp-Enyard, 2009; Delpierre, 1968; Mukherjee, 2008; Yee 
et al., 2016). This is partly because casein is widely available and tar-
geted by a vast range of proteases, making it a generic substrate. How-
ever, when casein-FITC was used in the protease bioassay for measuring 
LC fractions of snake venoms, the background signal was very high and 
variable among assays (see Supporting Information Fig. S2). As a 
consequence, increases in fluorescence due to proteolytic cleavage of the 
substrate by venom proteases was largely obscured. We therefore 
investigated the potential of a rhodamine substrate to achieve lower 
background signals and better sensitivity for proteolytic toxins in snake 
venoms. First, the concentrations of venom and substrates were evalu-
ated and optimized. Next, the performance of the casein-FITC and 
rhodamine substrates were compared. The optimal rhodamine-based 
protease bioassay, which showed to be superior to the FITC-based 
assy, was then applied to high-resolution LC fractions of venoms to 
and bioactivity chromatograms were constructed. These were used to 
correlate bioactivity of venom components with accurate masses ob-
tained with MS detection parallel to fractionation. 
As a critical note, we would like to mention that the original value of 
using a casein-FITC substrate is based in the variety of peptide bonds 
linked to the fluorescein label that are available for proteases; there are 
multiple fluorescein molecules chemically linked to casein via the 
reactive FITC molecule (i.e. chemically reactive fluorescein). This in-
creases the likelihood of enzymatic cleavage by proteases regardless of 
specificity. Although the current rhodamine substrate only has two small 
peptides to be cleaved from its structure in order to form the fluorescent 
product and as such represents less variety in available peptide bonds to 
be cleaved, the small amino acid sequence of the attached peptides is 
anticipated to compensate for this by easy access of proteases to the 
peptide cleavage sites in the rhodamine substrate. This hypothesis is 
strengthened by other studies in which it was found that similar or the 
same substrate showed broad-range specificity for proteases (Cai et al., 
2001; Grant et al., 2002; Kastrup et al., 2007; Klingel et al., 1994; Leytus 
et al., 1983; Zietek et al., 2018). This research showed the efficient and 
sensitive bioassaying of protease activity of several different crude 
venoms and of nanofractionated venom proteases. Although optimal 
protease activity cannot be expected for all SVMPs and SVSPs as it is not 
likely that the rhodamine substrate is a preferred substrate with optimal 
enzymatic kinetics for all venom proteases, it is expected that many 
proteases do convert the substrate at least to some extent. 
3.1. Effect of venom and substrate concentration in protease bioassay 
In order to compare casein-FITC, a conventional protease substrate, 
with the new rhodamine substrate, the minimum effective concentra-
tions of each substrate, as well as the effect of crude venom concentra-
tion, were determined. This was achieved by incubating five 
concentrations (33, 11, 4.0, 1.0 and 0.4 μg/mL) of three crude snake 
venoms (E. ocellatus, E. carinatus, and E. p. leakeyi) with three concen-
trations of rhodamine substrate (1.0, 0.5 and 0.1 μM) or casein-FITC 
substrate (30, 10 and 5.0 μg/mL). Fig. 1 displays the fluorescence re-
sults obtained for each venom at five concentrations using the 
rhodamine substrate (for three concentrations) and the casein-FITC (at 
one concentration). High venom concentrations in combination with 
low substrate concentrations resulted in rapid substrate depletion which 
is difficult to monitor kinetically (i.e. full substrate conversion at low 
substrate concentration occurs too fast to profile). High substrate con-
centrations provided high background signals, obscuring the fluores-
cence signal increase upon substrate conversion at low venom 
concentrations. 
When using 100 nM rhodamine substrate in the assay, only the 
highest venom concentration(s) (33 and/or 11 μg/mL) resulted in 
fluorescent signals that could be distinguished from the background. 
Still, at this low rhodamine substrate concentration, fluorescence in-
tensity increase was minimal during the assay due to substrate deple-
tion. When using high substrate and venom concentrations (i.e. 1000 nM 
and 33 μg/mL, respectively), intense fluorescence signals were obtained, 
but also high background signal. Moreover, consumption of substrate is 
significant. At a rhodamine substrate concentration of 500 nM, fluo-
rescence signals were clearly distinguishable from baseline and the 
enzymatic reaction rates were sufficiently slow to be observed in the 
proper kinetic time window. Although the rhodamine substrate was 
somewhat more costly, casein-FITC was found to be a less sensitive 
fluorescence indicator of protease activity. The rhodamine substrate also 
showed a more generic applicability exhibiting clear protease activity 
towards all tested venoms, which was not the case for the casein-FITC 
substrate. The significant difference in sensitivity is shown in Fig. 1 
(and in Fig. S1 for venoms of Daboia russelii russelii, Echis coloratus and 
Lachesis muta) demonstrating that the rhodamine-110-peptide substrate 
provides a clear advantage over casein–FITC. 
3.2. Bioactivity profiling of LC-fractionated snake venoms 
Casein-FITC (10 μg/mL) and the rhodamine substrate (500 nM) were 
also compared in bioassays applied to high-resolution venom fractions 
obtained after LC separation. Using casein-FITC, large signal to noise 
ratios were observed, resulting in protease activity being masked for 
most venoms (Fig. S2). Positive and negative control measurements 
(PBS þ casein-FITC and PBS only, respectively) showed that casein-FITC 
by itself produces substantial fluorescence background (i.e. increase in 
fluorescence intensity in time), even in the absence of proteolytic 
conversion. 
Using the rhodamine substrate for the same venom fractions, clear 
protease activity was observed for all venoms (Fig. S3). Regardless of the 
snake species, the bioactive venom proteases eluted within the 25–30 
min elution window, although differences in fluorescence peak intensity 
and shape were observed between species. A representative result ob-
tained for both substrates applied to the fractions of E. ocellatus is shown 
in Fig. 2. When using the rhodamine substrate, an increase in fluores-
cence slopes for wells containing eluted venom proteases was observed 
between 26 and 27 min. In wells without venom proteases, no substrate 
conversion occurred, as a constant baseline signal was observed (i.e. no 
slopes). 
3.3. Assignment of bioactive venom proteases 
The bioactivity profiles observed in the constructed bioassay chro-
matograms after LC fractionation were next correlated with mass data 
obtained by parallel MS detection. The bioactivity chromatograms were 
aligned with the UV and MS chromatograms taking delay times resulting 
from the flow volume to the fractionator into account. The positive 
peak/peaks in the bioactivity chromatograms, indicating protease ac-
tivity, were correlated with peak shapes and retention times of peaks 
observed in the UV chromatogram and in the total ion chromatogram 
(TIC) by superimposing the chromatograms. 
To identify accurate masses of bioactive components, we plotted the 
extracted ion chromatograms (XICs) that displayed peaks matching with 
the observed bioactivity peaks by shape and retention time. For 
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example, in Fig. 3 the peak for a component ion with a m/z of 2324.54 
(charge state, 14þ; deconvoluted mass, 30233 Da), nicely matched the 
detected bioactivity peak, indicating a venom protease. For the other 
venoms analyzed in this study, similar results were obtained (Fig. 4), 
showing the chromatographic window (20–30 min) in which the venom 
proteases elute. 
The MS and UV chromatograms of the studied venoms, which are all 
from the family Viperidae, showed characteristic profiles that can be 
considered a fingerprint for each specific venom. This can be explained 
by variation in venom toxin composition being ubiquitous among snake 
species (Casewell et al., 2014; Slagboom et al., 2017; Tasoulis and 
Isbister, 2017). All of the studied snake species produce hemotoxic 
venoms rich in proteases, but the number of these toxins, their relative 
abundance, and the ratio of serine proteases to metalloproteases varies 
among the species (Casewell et al., 2009; Choudhury et al., 2017; Pahari 
et al., 2007; Sanz et al., 2008). 
The additional detail observed in the UV and MS chromatograms 
reflects a number of venom components that are not visible in the 
bioassay (i.e. do not exhibit protease activity). The LC-UV data are 
particularly valuable as they allow comparison (i.e. correlation) with 
previous studies on the same snake venoms but in the context of other 
bioactivities. Several of the venoms studied here (E. ocellatus, 
Fig. 1. Comparison of bioassay readouts between the rhodamine substrate and casein-FITC. Different concentrations of crude snake venoms (33, 1, 4, 1 and 
0.4 μg/mL) were tested against three concentrations of rhodamine substrate (Column 1: rhodamine 100 nM; column 2: rhodamine 500 nM; column 3: rhodamine 
1000 nM). A comparison was then made with the optimized casein-FITC (Column 4: 10 μg/mL) bioassay. Row (a) Echis carinatus Row (b) Echis carinatus and Row (c) 
Echis pyramidum leakeyi. 
Fig. 2. Comparison of casein-FITC and rhodamine substrate bioassay readout. Red chromatogram: E. ocellatus þ casein-FITC substrate; blue chromatogram: E. 
ocellatus þ rhodamine substrate; X-axis: time (min). E. ocellatus venom was subjected to at-line nanofractionation after which the casein-FITC and rhodamine 
substrate bioassays were performed. Top: Fluorescence bioassay trace of nanofractionated E. ocellatus venom with casein-FITC substrate [10 μg/mL]. Bottom: 
Fluorescence bioassay trace of nanofractionated E. ocellatus venom with rhodamine substrate [500 nM]. (For interpretation of the references to color in this figure 
legend, the reader is referred to the Web version of this article.) 
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Calloselasma rhodostoma and Daboia russelli) have recently been assessed 
by Slagboom et al. (2019) in order to establish the coagulopathic ac-
tivities of venom toxins. This work included an in-depth identification 
study using accurate MS data in combination with bottom-up prote-
omics analysis of specific LC fractions. As Slagboom et al. used the same 
LC columns for venom separation, the LC-UV profiles of the venoms in 
the present and previous study could be readily compared and aligned. 
This allowed correlation of observed component peaks with mass and 
proteomics data previously obtained (Slagboom et al., 2019) and thus, 
identification of venom proteins responsible for the proteolytic bio-
activities observed. The mass and proteomics data obtained by Slag-
boom et al. for the elution window where protease activities were 
observed, provided multiple protein identities, which are displayed in 
full in Table 1. The venom toxin IDs were obtained by a previously 
performed Mascot database search on species-specific databases gener-
ated from transcriptomic data and on the Swissprot/Uniprot database 
when no transcriptomic data was available for the species. For details on 
the Mascot database and search parameters, readers are referred to the 
study of Slagboom et al. (2019). The majority of the resulting assigned 
toxin classes are known to exhibit proteolytic activity, and include 
SVMPs and SVSPs. Although a number of other venom toxin types were 
also detected, these were found co-eluting with the identified proteases, 
suggesting that they are likely not contributing to the detected activites. 
Evidence for this assertion is supported by the fact that these toxins 
were present at the same retention times as SVMPs and SVSPs. The 
toxins found in the area where protease activity was observed are 
tentative and each of these toxins can potentially exhibit the activity. 
However, suggestions based on the character of the toxin class can be 
made and in that sense the toxins that are most likely to be responsible 
for the activity are SVMPs and SVSPs. SVMPs and SVSPs are abundant in 
these species and are a main cause of venom-induced pathologies (Kini 
and Koh, 2016; Slagboom et al., 2017). For several of the bioactive peaks 
no clear corresponding XICs of m/z’s indicative of proteases were found. 
Most likely, the concentrations of these proteases are below the online 
MS detection limit. This might be due to poor ionization efficiencies, 
which is particularly true for proteins with a molecular mass above 25 
kDa. 
4. Conclusions 
This study describes the development of a rhodamine-110-peptide 
assay for profiling protease activity in both crude and LC fractionated 
venoms. Although it is considered the standard, the widely used casein- 
FITC substrate exhibits a significantly large background signal which 
resulted in low assay sensitivity and in the inability of integrating this 
substrate in nanofractionation analytics for post-column protease ac-
tivity assying of low amounts of venom. The new rhodamine-110 based 
fluorescence bioassay developed here, was shown to be considerably 
more sensitive than the standard casein-FITC bioassay for the mea-
surement of protease activity of viperid snake venoms in the nano-
fractionation set up. This is for example demonstrated in Fig. 2 where 
the casein-FITC based protease assay was unable to detect snake venom 
proteases due to the high background signal, while the rhodamine-110- 
substrate based assay showed clear bioactivity peaks. 
In total eight viper venoms were profiled for active proteases using 
the new assay in conjunction with LC. The combination of constructed 
bioactivity chromatograms with online detected UV chromatograms is 
useful for comparing LC-UV-MS data obtained by one study with LC-UV- 
MS and bioassay data obtained by another as shown in this study where 
observed bioactivity was cross-linked with UV, MS and proteomics data 
from Slagboom et al. by using the same LC conditions. For several 
bioactive peaks in this study, concentrations of corresponding venom 
proteases were found to be too low to be detected by the TOF mass 
spectrometer used. However, MS identification was still possible by 
using bottom-up proteomics data obtained for bioactive fractions, 
indicating a number of different snake venom proteases. These findings 
underline the value of this novel assay for the detection of bioactive 
proteases from biological samples such as snake venoms. Moreover, we 
suggest that the approach described herein could be readily applied for 
the screening and selection of novel inhibitory molecules and/or anti-
bodies for use as next generation treatments for snakebite (Ainsworth 
et al., 2018; Bulfone et al., 2018; Kini et al., 2018; Andreas H. Laustsen 
et al., 2018). 
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Fig. 3. Overlay of bioassay, UV and MS data. Fluorescence bioassay signal obtained with rhodamine substrate (blue), eXtracted Ion Chromatogram (XIC of m/z 
2325,54þ14 with an exact mass of 30233 Da; orange), UV trace (green; plotted only for the relevant time frame in which bioactivity was observed), and Total Ion 
Chromatogram (TIC; dotted black) traces of nanofractionated venom from Lachesis muta. X-axis: time (min). (For interpretation of the references to color in this figure 
legend, the reader is referred to the Web version of this article.) 
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Fig. 4. Eight examples of time correlated MS, UV, and protease activity traces of nanofractionated venoms from different viperid species. Top left: Echis ocellatus; 
top right: Lachesis muta; second from top left: Echis carinatus; second from top right: Echis coloratus; second from bottom left: Echis pyramidium leakeyi; second from 
bottom right: Daboia russelii; bottom left: Macrovipera lebetina; bottom right: Calloselasma rhodostoma. The TIC and UV traces, top/black and middle/green 
respectively, were obtained concurrently during the fractionation of the same sample of venom which was subsequently subjected to the rhodamine bioassay to 
produce the fluorescence bioactivity trace shown in blue at the bottom of each figure. Traces were adjusted (aligned) according to the delay time between system 
components. (For interpretation of the references to color in this figure legend, the reader is referred to the Web version of this article.) 
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